Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2007 1
2009 3
2010 10
2011 3
2012 5
2013 7
2014 2
2015 2
2016 6
2017 7
2018 5
2019 4
2020 7
2021 6
2022 5
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Bioavailability of Cariban® Capsules: A Modified-Release Fixed-Dose Combination of Doxylamine and Pyridoxine to Relieve Nausea and Vomiting During Pregnancy.
Saz-Leal P, Zamorano-Domínguez L, Frías J, Guerra P, Saura-Valls M, Roca-Juanes R, Nebot-Troyano J, García-Aguilar E, Vilchez T, Urso K. Saz-Leal P, et al. Among authors: frias j. Drugs R D. 2023 Jun;23(2):185-195. doi: 10.1007/s40268-023-00425-7. Epub 2023 Jun 15. Drugs R D. 2023. PMID: 37318714 Free PMC article.
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study.
Butta NV, Arias-Salgado EG, Monzón Manzano E, Acuña P, Álvarez Román MT, Buño-Soto A, Ramos Ramos JC, Belda-Iniesta C, Frías J, Carcas AJ, de Soto LM, de Miguel Buckley R, Lora D, García-Morales MT, Borobia AM, Arribas JR, Jiménez Yuste V; CombiVacS Study Group. Butta NV, et al. Among authors: frias j. Res Pract Thromb Haemost. 2023 Jan;7(1):100049. doi: 10.1016/j.rpth.2023.100049. Epub 2023 Jan 14. Res Pract Thromb Haemost. 2023. PMID: 36685004 Free PMC article.
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.
García-Pérez J, González-Pérez M, Castillo de la Osa M, Borobia AM, Castaño L, Bertrán MJ, Campins M, Portolés A, Lora D, Bermejo M, Conde P, Hernández-Gutierrez L, Carcas A, Arana-Arri E, Tortajada M, Fuentes I, Ascaso A, García-Morales MT, Erick de la Torre-Tarazona H, Arribas JR, Imaz-Ayo N, Mellado-Pau E, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Ochando J, Belda-Iniesta C, Frías J, Alcamí J, Pérez-Olmeda M; CombiVacS study Group. García-Pérez J, et al. Among authors: frias j. EClinicalMedicine. 2022 Jul 1;50:101529. doi: 10.1016/j.eclinm.2022.101529. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35795713 Free PMC article.
72 results